• P Tassani, R Kunkel, J A Richter, H Oechsler, H P Lorenz, S L Braun, G P Eising, F Haas, S U Paek, R Bauernschmitt, M Jochum, and R Lange.
• Department of Anesthesiology, German Heart Center Munich, Germany. tassani@dhm.mhn.de
• J. Cardiothorac. Vasc. Anesth. 2001 Aug 1; 15 (4): 469-73.

ObjectiveTo determine if prophylactic administration of C1-esterase-inhibitor would have a beneficial effect on postoperative weight gain and the inflammatory response in neonates undergoing cardiac surgery with cardiopulmonary bypass (CPB).DesignRandomized, double-blinded study.SettingUniversity-affiliated heart center.ParticipantsTwenty-four neonates with transposition of the great arteries.InterventionsIn group inhibitor (INH) patients (n = 12), 100 IU/kg of C1-esterase-inhibitor (Berinert) was given 30 minutes before CPB. In group placebo (P) patients (n = 12), placebo was administered instead. Interleukin (IL)-6, C3a anaphylatoxin, C1 activity, prekallikrein, Hageman factor, D-dimers, and clinical parameters were measured 6 times perioperatively.Measurements And Main ResultsAll 24 patients had an uneventful clinical course. Mean arterial pressure and pulmonary oxygenation after CPB were superior in group INH patients. The weight gain on postoperative days 1 to 4 was significantly less in group INH patients compared with group P (55 +/- 59 g vs. 340 +/- 121 g, day 1). The concentration of IL-6 (76 +/- 17 pg/mL vs. 262 +/- 95 pg/mL during CPB) was significantly lower in group INH patients compared with group P patients. In contrast, no influence on C3a anaphylatoxin and coagulation factors was found.ConclusionProphylactic application of C1-esterase-inhibitor in neonates undergoing arterial switch operations produces less inflammatory response compared with placebo. This difference may have contributed to improved clinical parameters, including less weight gain postoperatively.Copyright 2001 by W.B. Saunders Company.

28 keywords...

hide…